Professional Documents
Culture Documents
Unit 6 Med
Unit 6 Med
3
TOPIC OUTLINE
q SYMPTOMATOLOGY:
1. Polyuria.
2. Oliguria.
3. Nocturia.
4. Haematuria.
5. Pyuria or Dysuria.
6. Enuresis.
5.1.1 Explain genito urinary system & male reproductive system
symptomatology.
q SYMPTOMATOLOGY:
1. Polyuria.
v Normal urine output in adult is 15ooml. per day.
v Polyuria is a condition usually defined as excessive or abnormally large
production or passage of urine greater than 2500ml. per day in adults).
v Increased production and passage of urine may also be termed diuresis.
v The most common cause of polyuria in both adults and children is
uncontrolled diabetes mellitus causing an osmotic diuresis.
5.1.1 Explain genito urinary system & male reproductive system
symptomatology.
q SYMPTOMATOLOGY:
1. Polyuria.
v Other causes are:
§ Excessive secretion of aldosterone due to adrenal cortical tumor,
§ Primary polydipsia (excessive fluid drinking).
§ Central diabetes insipidus.
§ Nephrogenic diabetes insipidus.
5.1.1 Explain genito urinary system & male reproductive system
symptomatology.
q SYMPTOMATOLOGY:
2. Oliguria.
v Oliguria or hypouresis is the low output of urine. It is clinically classified as
an output more than 100 ml/day but less than 400ml/day.
v The decreased output of urine may be a sign of:
§ Dehydration.
§ Kidney failure.
§ Hypovolemic shock.
§ Urinary tract .
5.1.1 Explain genito urinary system & male reproductive system
symptomatology.
q SYMPTOMATOLOGY:
2, Oliguria.
v The most extreme type of oliguria is called anuria.
v Anuria is defined or clinically classified as less than 50ml. urine output per
day.
5.1.1 Explain genito urinary system & male reproductive system
symptomatology.
q SYMPTOMATOLOGY:
3. Nocturia.
v Excessive urinating at night. Nocturia can be normal and more common with
aging.
v It is important to assess underlying causes such as diabetes or urinary
infection.
v Nocturia is a common symptom in both men and women.
v It can be troublesome in itself, by disturbing sleep, and can have a significant
impact on quality of sleep and quality of life.
v Nocturia is a symptom, not a diagnosis.
5.1.1 Explain genito urinary system & male reproductive system
symptomatology.
q SYMPTOMATOLOGY:
4. Haematuria.
q SYMPTOMATOLOGY:
5. Pyuria or Dysuria.
v Pain during urination, or difficulty urinating. This pain can occur before and
after urinate. Dysuria is usually caused by inflammation of the urethra,
frequently as a result of infection.
v Most common bacteria that causes UTIs is Escherichia coli (E. coli), which is
found in the gastrointestinal (GI) tract.
v May complain of feeling like to urinate several times a day (urinary
frequency) or like to urinate immediately (urinary urgency) but very little
urine comes out.
v Men are also more likely than women to complain of taking longer to begin
urinating.
5.1.1 Explain genito urinary system & male reproductive system
symptomatology.
q SYMPTOMATOLOGY:
6. Enuresis
LEARNING OUTCOMES
q Tuberculosis of the kidney and urinary tract is, like other forms of the disease.
q Caused by members of the Mycobacterium tuberculosis complex. By far the most
common causative organism is the human tubercle bacillus, M. tuberculosis, but
the bovine tubercle bacillus, M. bovis, occasionally can be responsible.
q The vaccine strain, Bacille Calmette-Guérin (BCG), also has been the cause of renal
lesions as a complication of intravesical instillation of BCG for the treatment of
superficial bladder cancer.
5.2.1 – 5.2.4 T.B. KIDNEY, CYSTITIS, ORCHITIS AND EPIDYDIMITIS.
v The elderly.
v Homeless people.
v People with substance use problems.
v Weakened immune systems from HIV or AIDS (acquired immune
deficiency syndrome).
v Close or frequent contact with someone who has active TB symptoms.
Health care workers who may be exposed to patients with active TB.
5.2.1 – 5.2.4 T.B. KIDNEY, CYSTITIS, ORCHITIS AND EPIDYDIMITIS.
q CONSTITUTIONAL SYMPTOMS.:
LEARNING OUTCOMES
At the end of this chapter, students will be able to:
• Define cystitis.
• State the causes of cystitis..
• State the clinical manifestation of cystitis.
• Explain the management of cystitis.
5.2.1 – 5.2.4 T.B. KIDNEY, CYSTITIS, ORCHITIS AND EPIDYDIMITIS.
q Affects people of both sexes and all ages but more common
among females than males.
5.2.1 – 5.2.4 T.B. KIDNEY, CYSTITIS, ORCHITIS AND EPIDYDIMITIS.
v Sex. Frequent and/or vigorous sex increases the chances of physical damage
or bruising to the urethra and bladder, which in turn makes the likelihood of
cystitis developing higher.
v Poor hygiene can cause cystitis. Women have shorter urethras than men. A
woman's urethra opening is much nearer the anus than a man's.
Consequently, there is a higher risk of bacteria entering the urethra from
the anus.
v Does not empty his/her bladder completely, creating an environment for
bacteria to multiply in the bladder. Fairly common among pregnant women,
and also men whose prostates are enlarged.
v Diabetes. Urine can contain more sugar than usual. Passing urine that
contains more sugar than usual can encourage bacteria to grow in the
bladder and urethra.
5.2.1 – 5.2.4 T.B. KIDNEY, CYSTITIS, ORCHITIS AND EPIDYDIMITIS.
v Kidney or bladder stones. These can prevent your bladder from emptying
fully, which can encourage bacteria to grow. In men, a common cause of
cystitis is passing urine less often because the prostate is enlarged.
5.2.1 – 5.2.4 T.B. KIDNEY, CYSTITIS, ORCHITIS AND EPIDYDIMITIS.
39
. Urethritis:
40
. Urethritis:
41
. Incidence:
. Is a communicable disease.
. Mostly spread through sexual
contact and mostly occur in men.
. In woman is usually associated
with cytitis or vaginitis.
42
. Etiology:
a. Mongonococcal urethritis:
. Trichomonas vaginitis.
. Herpes simplex.
b. Gonococcal urethritis:
. Neisseria gonorrhoea.
c. Nonsexually transmitted:
. Bacterial urethritis.
. Trauma.
43
. Clinical Manifestation:
. Usually asymptomatic.
. Itching and burning around area of
urethra.
. Urethral discharge:
. Scanty or profuse.
. Thin, clear or mucoid.
. Thick and purulent (gonococcal).
. Dysuria, frequency and urgency.
. Penile discomfort.
. Nocturia.
. Microscopic or gross haematuria
44
. Diagnostic Evaluation:
45
. Management:
. Antibiotic:
. Im Procain Penicillin 2.4 gram.
. Capsule Ampicillin 2gram.
. Mist Potassium citrate 15 ml. tds to
relieve dysuria.
. Avoid sexual contact until heal.
46
. Nursing Care:
. Rest in bed.
. Drink plenty of water.
. Personal cleanliness especially in
the genitals.
. Patient partners or contacts to go
for examination and treatment.
47
. Complications:
. Prostatitis.
. Urethral stricture.
. Sterility.
. Salpingitis and ovaritis.
. Septicaemia.
. Epididimitis.
. Rectal infection, pharyngitis,
conjunctivitis.
48
Assessment:
. Obtain history.
. Assess signs and symptoms.
. Perform genital and abdominal
examination to assess for extent of
infection.
49
. Patient education and Health
Maintenance:
. Advise safer sex practices.
. Questions about voiding habits and
personal hygiene practices.
. Follow-up.
50
. Glomerulonephritis:
. Definition
. Risk factor.
. Etiology & pathophysiology.
. Clinical manifestations.
. Diagnostic evaluation.
. Clinical management.
. Complications.
. Nursing diagnosis.
. Discharge planning and teaching.
51
. Definition:
. Inflammation of the glomeruli
arising from an immune response of
the body.
52
. Glomerulonephritis:
53
. Etiology:
54
2. Infection:
. Bacterial: Streptococcus.
. Viral:
. Mumps.
. Measles.
. Hepatitis B.
. Parasite:
. Toxoplasma.
. Rickettsia.
. Malaria.
55
3. Drugs: NSAID (non-steroid
anti inflammatory drug).
4. Maglinancy:
. Carcinoma:
. Colon, lung, stomach and breast.
56
. Presentation:
. Proteinuria
. Nephrotic syndrome.
. Chronic renal failure.
57
. Clinical Manifestation:
. Bacterial streptococcal infection 7-
14 days.
. Tonsilitis.
. URTI.
. Early clinical manifestation include:
. Macroscopic haematuria.
. Proteinuria.
. Tea coloured urine and oliguria.
. Elevated ESR.
. Elevated anti streptolysine O titer.
. Later chemical manifestation:
. Circulatory congestion.
. Hypertension.
. End-stage renal failure.
. Generalised body oedema as a result
of decreased glomerular filtration.
. Oedema in the face around the eye
(Periorbital oedema) and puffiness
of the face.
58
. Later involved total body:
. Ascities.
. Peripheral oedema in the legs.
. Smoky urine indicative of bleeding in
upper urinary tract.
. Cardiomegaly and cardiac failure.
. Lethargy and anoreksia.
59
. Diagnostic Evaluation:
. Assess for signs and symptoms.
. Urine analysis:
. Urine is characterized by dark
brown colour.
. Macroscopic haematuria,
. Proteinuria.
. Microscopic studies:
. RBC.
. WBC.
. Epithelial and pus cell.
. Throat swab for culture.
. Blood studies:
. BUSE.
. Low serum albumin.
. High serum lipids.
. Increased creatinine.
. ASOT - Increased Anti-streptolysis
O titre.
. Anti-nuclear antibody - SLE.
60
. Chest xray to detect cardiomegaly
and pulmonary oedema.
. Renal biopsy.
61
. Diagnosis assessment:
. Patient’s history.
. Clinical manifestation.
. Physical examination.
. Laboratory investigation.
62
. Differential Diagnosis:
. Nephrotic syndrome.
. Acute renal failure.
. Chronic renal failure.
. Acute pyelonephritis.
. SLE.
63
. Management:
1. Renal function promotion:
. Bed rest during acute illness.
. Observe fluid balance. Intake
and output chart.
. Restriction of fluid, sodium and
calcium.
. Restriction of dietary protein
when oliguria is present.
Weigh twice daily.
. Carbohydrates increased to provide
energy and reduce catabolism of
protein.
64
2. Prevention and complication:
65
4. Patient education:
. Follow up to assess:
. Blood pressure.
. Proteinuria.
. Blood urea.
. Advise to seek treatment for any
infection.
. Get early treatment for signs of
renal failure.
66
. Complications:
67
. Discharge teaching:
68
. Nephrotic syndrome:
. Definition.
. Risk factors & etiology.
. Pathophysiology.
. Clinical manifestations
. Diagnostic evaluation.
. Clinical management.
. Complications.
. Nursing diagnosis.
69
. Nephrotic syndrom:
. Definition:
. Clinical disorder characterised by
masih proteinuria with generalized
edema, hyperlipidemia,and
decrease in albumin in the blood.
. Causes damage to the glomeruli
with resultant proteinuria.
. Most often seen in children 1 – 5
years.
70
. Nephrotic syndrome:
71
. Nephrotic syndrome:
72
. Etiology:
. Glomerulonephritis.
. Diabetic nephropathy.
. Pharmacologic agents:
. NSAIDs.
. ACE inhibitor - Captopril.
. Drug abuse - Heroin.
. Allergic response to:
. Toxins.
. Pollens.
. Insect stings.
. Infections:
. Bacterial: (streptococcal, syphillis).
. Viral: (herpes zoster, HIV and
Hepatitis)
73
. Pathophysiology:
74
. Clinical Manifestation:
. Umur 1 – 5.
. Male children more than female.
. Oedema:
. Appear slowly.
. Pitting oedema of extremities and
around the eye.
. Generalised oedema - ascitis,
pleural effusion and scrotal
oedema.
. Proteinuria.
. Hipoalbuminemia:
. Increased albumin secretion.
. General symptoms:
. Prolonged loss of protein.
. Anoreksia.
. Muscle wasting.
. Tiredness.
. Dyspnoea.
. Microscopic haematuria.
75
. Diagnostic investigation:
1. Urine:
. 24 hours urine for protein.
. FEME:
. RBC.
. Cast.
. Masive protein >5g/day.
2. Blood:
. Serum protein.
. Serum lipid.
. Serum albumin.
. BUSE.
. Serum creatinine.
. Blood glucose.
3. Renal biopsy.
76
. Clinical management:
. General:
. Bed rest.
. Diet - Normal protein with
sufficient calorie.
Less sodium.
. Restrict water intake.
. Diuretic - lasix to treat oedema.
. Antibiotic - Penicillin to treat
infection.
. Administration of albumin to
increase plasma oncotic pressure
and replace losses.
2. Specific:
. Corticosteroid therapy -
prednisolone.
77
. Prevention and treatment of
complications:
78
. Complications:
79
Discharge planning & teaching.
. Teach the pt to collect urine
specimen and evaluate the urine for
P.H, calcium and protein.
. Make sure that pt understands
medications dosage, and its side
effects.
. Emphasize the potential for relapse
of symptoms and the necessity of
prompt care.
. Proper teaching about diet.
80
. Pyelonephritis.
. Definition.
. Types.
. Causes.
. Risk factors.
. Pathophysiology.
. Diagnosis.
. Clinical manifestations.
. Management.
. Complications.
81
. Definition.
. Types.
. Acute Pyelonephritis.
. Chronic Pyelonephritis.
82
. Acute Pyelonephritis:
. Often occurs after bacterial
contamination of the urethra or
following an invasive procedure of
the urinary tract.
. Chronic Pyelonephritis:
. Most commonly occurs following
chronic obstruction with reflux or
chronic disorder.
83
. Etiology:
1. Bacterial infection:
. Escherichia coli (75%)
. Most common cause.
. Streptococcal faecalis.
. Straphylococci aureus.
2. Obstruction:
. Enlarged prostate gland.
. Renal calculi.
. Congenital abnormality.
. During pregnancy.
84
. Risk factors.
. Urinary retention.
. Immobilization.
. Indwelling catheter.
. Calculi.
. Pregnancy.
. Dehydration.
85
. Pathophysiology.
. Pathogen enters the urinary
system through the ascending
urethral route.
. Urinary system become inflamed.
. Polymorphonucleocutes produced
in the urine.
. In chronic Pyelonephritis the
kidney become scarred, contracted
and nonfunctioning.
86
. Diagnostic evaluation:
87
. Clinical manifestations:
. Sudden onset.
. Fever, chills and headache.
. Nausea and vomiting.
. Flank pain.
. Muscular pain.
. Dysurea , cloudy bloody and foul
smelling urine.
. Increased white blood cells in the
urine.
. Frequency and urgency
88
. Differential diagnosis:
. Acute appendicitis.
. Acute cholecytitis.
. Acute salpingitis.
. Acute cystitis.
. Vesical calculi.
89
. Management:
. Antibiotic therapy:
. IV Ampicillin 500mgm. QID.
. IV Gentamycin 40 - 80mg TDS.
. IV Kanamycin 500mg. BD.
. Symptomatic treatment:
. Paracetamol for fever.
. Stemetil for vomiting.
90
. Ward mx:
. Bed rest.
. Monitor vital signs.
. Monitor intake and output chart.
. Monitor weight
. Encourage fluid intake up to
3liters/day.
. Diet high in protein.
91
. Complications:
. Chronic pyelonephritis.
. Septicaemia.
. Renal failure.
. Pelvic abscess.
92
. Health education:
93
Renal failure:
94
6. Renal failure:
. Definition.
. Types.
. Pathophysiology.
. Phases.
. Causes.
. Clinical manifestations.
. Clinical management.
. Nursing interventions.
95
. Definition:
96
. Types:
1. Acute.
2. Chronic.
97
. Risk factors:
. Hypertensive episodes.
. Recent surgery.
. Multiple organ failure.
. Renal disease.
. Diabetes.
. Nephrotoxic substance.
98
. Etiology:
99
. Etiology:
100
. Etiology:
101
. Renal failure:
102
. Pathophysiology:
103
2. Excretion is impaired allowing
substances normally eliminated to
accumulate in body fluids.
3. Homeostatic, endocrine, and
metabolic functions are disrupted.
104
. Clinical manifestation:
a. Urinary:
. decreased urine output.
. Proteinuria.
. Decreased specific gravity.
. Increased urinary sodium.
105
b. Respiratory:
. Pulmonary edema.
. Kussmaul respirations deep rapid
respiration.
. Pleural effusion.
106
c. Cardiovascular:
. Volume overload.
. Congestive heart failure.
. Hypotention or hypertention.
. Pericarditis.
. Arrhythmias.
107
d. Gastrointestinal:
108
e. Hematologic:
. Anemia.
. Leucocytosis.
. Defect in platelet functioning.
109
f. Neurological:
. Lethargy.
. Seizures.
. Memmory impairment.
110
g. Metabolic:
. Increased creatinine.
. Increased potassium.
. Decreased P.H.
. Decreased bicarbonate.
. Decreased calcium.
. Decreased sodium.
111
. Phases of acute renal failure.
112
1. Initiating phase:
. Begins at the time of insult and
continues until the signs and
symptoms become apparent.
. Last hours to days.
113
2. Oliguric phase:
114
3. Diuretic phase:
115
4. Recovery phase.
116
. Diagnostic evaluation:
117
. Clinical management:
118
. Nutritional therapy:
119
. Total parenteral nutrition:
120
. Indication for dialysis:
. Volume overload.
. Elevated potassium level with
E.C.G changes.
. Metabolic acidosis.
. (bicarbonate level less than
15meq/l).
. Significant changes in mental
status.
. Pericarditis.
. Pericardial effusion.
121
. Chronic renal failure: (End stage).
. Definition:
. A progressive irreversible
deterioration in renal function
in which the body’s ability to
maintain metabolic and fluid
and electrolyte balance fails
resulting in uremia or azotemia.
(retention of urea and other
nitrogenous waste in the blood).
122
. Etiology:
123
. Clinical manifestation:
. Neurologic:
. Weakness.
. Fatigue.
. Confusion.
. Inability to concentrate.
. Disorientation.
. Seizures.
124
. Integumentary:
125
. Cardiovascular:
. Hypertension.
. Pitting edema.
. Periorbital edema.
. Engorged neck veins.
. Hyperkalemia.
. Pericarditis.
126
. Pulmonary:
. Crackles.
. Thick tenacious sputum.
. Pleuritic pain.
. Shortness of breath.
. Tachypnea.
. Kussmaul respiration
127
. Gastrointestinal:
128
. Hematologic:
. Anemia.
. Thrombocytopenia.
. Reproductive:
. Amenorrhea.
. Testicular atrophy.
. Infertility.
129
. Musculoskeletal:
. Muscle cramps.
. Loss of muscle strength.
. Bone pain.
. Bone fracture.
. Foot drop.
130
. Pathophysiology:
. As renal function declines:
. Retention of sodium and water
causes edema, heart failure,
hypertension, ascites.
. Decreased renal insufficiency
causes renal failure.
. Uremia develops and adversely
affect every system of the body.
. Erythropoietin production by the
kidney decreases, causing
profound anaemia.
131
. Stages of renal failure:
. Stage 1:
. Reduced renal reserve.
. 40-75% loss of nephron function.
. Pt does not have any symptoms.
. Stage2:
. Renal insufficiency.
. 75-90% loss of nephron function.
132
. Stage3:
. End stage renal disease.
. Less than 10% of renal function
remaining.
133
. Complications:
. Hyperkalemia.
. Pericarditis.
. Hypertension.
. Pulmonary edema.
. Pneumonia.
. Anemia.
. Bone disease.
. Peptic ulcer .
134
. Management:
. Pharmacological therapy:
. Antacids:
. Aluminium based antacids to
treat hypocalcaemia.
. Antihypertensive and
cardiovascular agents.
. Antiseizure agents:
. Intravenous diazepam or
phenytoin.
135
. A hormone produced by the kidney
that stimulate the production of
R.B.C in the bone marrow.
136
. Nutritional therapy:
137
. Fluid allowances is 500-600ml more
than the previous day’s 24-hr urine
output.
138
. Other therapy:
. Dialysis peritoneal or
haemodialysis.
. Kidney transplant.
139
LIST OF REFERENCES